Pell Bio Med Technology Co Ltd
TWSE:6949
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Pell Bio Med Technology Co Ltd
Inventory
Pell Bio Med Technology Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pell Bio Med Technology Co Ltd
TWSE:6949
|
Inventory
NT$6.2m
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
GenMont Biotech Inc
TWSE:3164
|
Inventory
NT$70.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
3%
|
|
|
Adimmune Corp
TWSE:4142
|
Inventory
NT$786.1m
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
|
E
|
Energenesis Biomedical Co Ltd
TWSE:6657
|
Inventory
NT$864k
|
CAGR 3-Years
13%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Kim Forest Enterprise Co Ltd
TWSE:6645
|
Inventory
NT$139.2m
|
CAGR 3-Years
17%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Pell Bio Med Technology Co Ltd
Glance View
Pell Bio-Med Technology Co., Ltd. operates as a biotechnology company. The company is headquartered in Taipei City, Taipei. The company went IPO on 2024-03-08. The main business focuses on immune cell therapy that uses genetic engineering to modify the patient's own immune cells. The firm is engaged in the development of chimeric antigen receptor T cell therapy for the treatment of B-cell lymphoma PL001. Non-genetically modified cell therapy products include cytokine-induced killer cells (CIK), and mixed cells using a combination of dendritic cells and cytokine-induced killer cells (DC-CIK). Non-cell products include hair care products and others.
See Also
What is Pell Bio Med Technology Co Ltd's Inventory?
Inventory
6.2m
TWD
Based on the financial report for Dec 31, 2024, Pell Bio Med Technology Co Ltd's Inventory amounts to 6.2m TWD.
What is Pell Bio Med Technology Co Ltd's Inventory growth rate?
Inventory CAGR 3Y
13%
Over the last year, the Inventory growth was 64%. The average annual Inventory growth rates for Pell Bio Med Technology Co Ltd have been 13% over the past three years .
